Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: Results from a multicenter phase I/IIa clinical trial

International Journal of Colorectal Disease

Volumn 28, Issue 3, 2013, Pages 313-323

  De La Portilla, F ^a   Alba, F ^b   Garcia Olmo D ^c   Herrerias J M ^d   Gonzalez F X ^e   Galindo, A ^f  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b H San Juan de Dios   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Allogeneic adult stem cells; Fistulizing Crohn's disease; Perianal fistula

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVERSE OUTCOME; ALLOGENEIC STEM CELL TRANSPLANTATION; ANUS FISTULA; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; EPITHELIZATION; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; HUMAN; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIANAL ABSCESS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTALGIA; THERAPY EFFECT; UTERUS MYOMA;

ADIPOSE TISSUE; ADULT; CELL PROLIFERATION; CROHN DISEASE; DEMOGRAPHY; FEMALE; HUMANS; MALE; RECTAL FISTULA; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84879459518     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1581-9     Document Type: Article

References (50)

1. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458-466 (Pubitemid 351733422)
2. Hellers G, Bergstrand O, Ewerth S et al (1980) Occurrence and outcome after primary treatment of anal fistula in Crohn's disease. Gut 21:525-527 (Pubitemid 10059414)
3. Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn's disease in Olmsted Country, Minnesota. Gastroenterology 122:875-880 (Pubitemid 34267269)
4. Tozer PJ, Burling D, Gupta A et al (2011) Review article: medical, surgical and radiological management of perianal Crohn's fistulas. Aliment Pharmacol Ther 33:5-22
5. Singer NG, Caplan AI (2011) Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6:457-478
6. Delarosa O, Dalemans W, Lombardo E (2012) Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol 23:1-5
7. Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843 (Pubitemid 34534559)
8. Krampera M, Glennie S, Dyson J et al (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729 (Pubitemid 36857965)
9. Ghannam S, Pène J, Torcy-Moquet G et al (2010) Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 185:302-312
10. Prigione I, Benvenuto F, Bocca P et al (2009) Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 27:693-702
11. Corcione A, Benvenuto F, Ferretti E et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372 (Pubitemid 43053565)
12. Raffaghello L, Bianchi G, Bertolotto M et al (2008) Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26:151-162
13. Delarosa O, Sánchez-Correa B, Morgado S et al (2012) Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev 21:1333-1343
14. Doorn J, Moll G, Le Blanc K et al (2012) Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 18:101-115
15. DelaRosa O, Lombardo E, Beraza A et al (2009) Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 15:2795-2806
16. Krampera M (2011) Mesenchymal stromal cell 'licensing': a multistep process. Leukemia 25:1408-1414
17. Le Blanc K, Tammik C, Rosendahl K et al (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896 (Pubitemid 37211373)
18. Mitchell JB, McIntosh K, Zvonic S et al (2006) Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24:376-385 (Pubitemid 44464807)
19. Gonzalez-Rey E, Anderson P, González MA et al (2009) Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929-939
20. González MA, Gonzalez-Rey E, Rico L et al (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989
21. Garcia-Olmo D, Garcia-Arranz M, Garcia LG et al (2003) Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 18:451-454 (Pubitemid 37062740)
22. Garcia-Olmo D, Garcia-Arranz M, Herreros D et al (2005) A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416-1423 (Pubitemid 40933870)
23. Garcia-Olmo D, Herreros D, Pascual I et al (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79-86
24. Ciccocioppo R, Bernardo ME, Sgarella A et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60:788-798
25. Van Assche G, Dignass A, Reinisch W et al (2010) The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohn's Colitis 4:63-101
26. Nikfar S, Mirfazaelian H, Abdollahi M (2010) Efficacy and tolerability of immunoregulators and antibiotics in fistulizing Crohn's disease: a systematic review and meta-analysis of placebo-controlled trials. Curr Pharm Des 16:3684-3698
27. Pearson DC, May GR, Fick GH et al (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123:132-142
28. Sands BE, Anderson FH, Bernstein CN et al (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350:876-885 (Pubitemid 38252535)
29. Roumeguère P, Bouchard D, Pigot F et al (2011) Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study. Inflamm Bowel Dis 17:69-76
30. Bourikas LA, Koutroubakis IE (2010) Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice. Curr Drug Targets 11:187-197
31. Alessandroni L, Kohn A, Cosintino R et al (2011) Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study. Tech Coloproctol 15:407-412
32. Wise PE, Schwartz DA (2006) Management of perianal Crohn's disease. Clin Gastroenterol Hepatol 4:426-430
33. Singh B, George BD, Mortensen NJ (2007) Surgical therapy of perianal Crohn's disease. Dig Liver Dis 39:988-992 (Pubitemid 47354988)
34. Whiteford MH, Kilkenny J 3rd, Hyman N et al (2005) Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum 48:1337-1342 (Pubitemid 40933859)
35. Lewis RT, Maron DJ (2010) Anorectal Crohn's disease. Surg Clin North Am 90:83-97
36. Grimaud JC, Munoz-Bongrand N, Siproudhis L et al (2010) Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology 138:2275-2281
37. English K, Mahon BP (2011) Allogeneic mesenchymal stem cells: agents of immune modulation. J Cell Biochem 112:1963-1968
38. Uccelli A, Moretta L, Pistoia V (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566-2573 (Pubitemid 44608440)
39. Krampera M, Cosmi L, Angeli R et al (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398 (Pubitemid 44464808)
40. Van Laar JM, Tyndall A (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 45:1187-1193 (Pubitemid 44542057)
41. Griffin MD, Ritter T, Mahon BP (2010) Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 21:1641-1655
42. Rubio D, Garcia S, De la Cueva T et al (2008) Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res 314:691-698
43. Røsland GV, Svendsen A, Torsvik A et al (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69:5331-5339
44. Garcia S, Bernad A, Martín MC et al (2010) Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res 316:1648-1650
45. Torsvik A, Røsland GV, Svendsen A et al (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res 70:6393-6396
46. Prockop DJ, Brenner M, Fibbe WE et al (2010) Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12:576-578
47. Malouf AJ, Buchanan GN, Carapeti EA et al (2002) A prospective audit of fistula-in-ano at St. Mark's hospital. Colorectal Dis 4:13-19 (Pubitemid 34285250)
48. Jurczak F, Laridon JY, Raffaitin P et al (2004) Biological fibrin used in anal fistulas: 31 patients. Ann Chir 129:286-289 (Pubitemid 38833556)
49. Taxonera C, Schwartz DA, Garcia-Olmo D (2009) Emerging treatments for complex perianal fistula in Crohn's disease. World J Gastroenterol 15:4263-4272
50. Schaffzin DM, Stahl TJ, Smith LE (2003) Perianal mucinous adenocarcinoma: unusual case presentations and review of the literature. Am Surg 69:166-169